How to make ultrasound zap tumors in a moving organ

Researchers led by the Fraunhofer Institute for Medical Image Computing think they’ve overcome the challenges standing in the way of using ultrasound to kill cancer tumors in organs that move with breathing. Until now, health practitioners have mostly limited ultrasound to treating prostate cancer, bone metastases and uterine myoma, according to the Fraunhofer Institute (Bremen, Germany). Organs

Why surgical stapling is a hot medical device product

The global increase in laparoscopic surgeries, particularly bariatric, is leading to a greater reliance on surgical staples, says a report on the Surgical Stapling Devices Market from Future Markets Insight. Close to $2 billion worth of surgical stapling devices were sold in the world last year, and revenues are expected to double by the end of 2026. Time savings,

Arch Therapeutics liquid device stops bleeding immediately

Arch Therapeutics has developed a technology it says is able to control bleeding and leakage during surgery and trauma. The technology, known as the AC5 surgical hemostatic device, is able to stop bleeding immediately, with a elapsed time of 10 seconds. Other methods of hemostasis take anywhere between 180 and 300 seconds. Dr. Terrance Norchi,

Healthcare robots: 5 ways they are getting even better

Think robots and healthcare, and surgical robotics often comes to mind. But there are so many other ways that robotics is transforming modern health settings. In addition to revolutionizing surgery, researchers and companies have explored robots for hospital logistics, disinfecting, nursing, exoskeletons for rehabilitation, and prosthetic limbs. A recent research report by Tractica predicts that the

Pages: 1 2 3 4 5 6

Turns out knee surgery can hold even in heavier patients

Increased body mass index is actually a poor predictor of whether a common type of knee surgery, meniscal repair, will fail, according to new research out of Ohio State University. The results matter because experts assumed that BMI plays a role when it came to the roughly 15% of meniscal repairs that fail, said Dr. David

Medtech stories we missed this week: March 3, 2017

Several clinical study results were published this week, while other companies reached distribution deals. Here are some medtech stories we missed this week but were still worth mentioning. 1. Health Canada approves Ventripoint’s complete heart analysis system for 2D ultrasounds Ventripoint Diagnostics received a license from Health Canada for its new VMS-Plus machine and the 4-chamber

Paragon 28 releases aseptically processed allograft solution

Paragon 28 has released its newest allograft solution, the Preserve HammerGraft System, which is its first aseptically processed hammertoe allograft. Paragon 28 specializes in foot and ankle surgery solutions that help benefit surgeons and patients. The HammerGraft System adds to the Preserve line that is processed without gamma radiation and bleaching and has greater structural

Hill-Rom enhances surgical solutions portfolio with launch of mobile surgical table

In response to hospitals’ need to equip operating rooms with quality medical devices at a reasonable cost, Hill-Rom designed and developed the new TruSystem 3000 Mobile Operating Table. The introduction of this surgical table enhances the Hill-Rom Surgical Solutions product portfolio by providing a cost-effective, reliable and flexible operating table. The TruSystem 3000 Mobile Operating

Safe Orthopaedics releases connectors and cement injectables for spinal surgery

Safe Orthopaedics has released its transverse connector that it designed to rigidify the stabilization of posterior spinal osteosynthesis, and a injectable cement for Cypress screws. The cement injectables that go into the vertebrae improve the anchoring strength of Cypress screws. Improving the strength reduces the risk of postoperative instability and the need to have surgery

How surgical robots are creating super surgeons

Faster than a scalpel-wielding hand, able to snake to hard-to-reach surgical sites in a single bound—future surgeons will be super surgeons, all thanks to robotics. Alistair Fleming, VP Medical at Sagentia In many industries, the advance of robotics has created worries about robots supplanting humans. But in the world of surgery, the next generation of

This tiny camera on a needle could enable safer brain surgeries

A team of researchers at the Center for Nanoscale BioPhotonics at the University of Adelaide in Australia have developed a brain biopsy needle with a tiny camera attached to the end to make brain surgery safer. When performing surgery on a brain tumor, regular biopsy needles usually pose the risk of hitting a blood vessel,

11 surgical robotics companies you need to know

Fink Densford, Associate Editor Robotic surgery is taking off, and the field is becoming increasingly diverse. We’ve collected information on the biggest players in the field so far. Intuitive Surgical’s da Vinci robot remains the premier surgical robotics company, with other companies including Stryker and Zimmer-Biomet only getting into the field in recent years. Read on

Pages: 1 2 3 4 5 6 7 8 9 10 11 12

Exploring ePTFE sutures for surgical product development

Zeus Industrial Products has developed an expanded polytetrafluoroethylene (ePTFE) suture based on physicians’ needs. In this podcast, Bruce Anneaux, corporate director of research and development at Zeus, reviews the material properties of Aeos ePTFE and the company’s latest offering, a suture monofilament. The structure of the Aeos material consists of solid nodes interconnected by a matrix of

Intuitive Surgical expects slowdown in da Vinci sales growth

Intuitive Surgical beat Wall Street expectations with its fourth quarter results, but company officials expect a slowdown in sales growth this year for da Vinci surgical robots. Intuitive Surgical earned $204 million, or $5.13 per share, off $386 million in sales during the three months ended Dec. 31, 2016, the company reported Tuesday evening. The fourth

Medtronic launches trial for Visualase MRI-Guided laser ablation device in epilepsy patients

Medtronic (NYSE:MDT) said today that the 1st procedure using the Visualase MRI-Guided laser ablation system has been performed in its SLATE clinical trial evaluating the device in patients with drug-resistant mesial temporal lobe epilepsy. The trial is slated to enroll 120 patients with MTLE, the most common form of epilepsy. Researchers will observe the patients